Results 141 to 150 of about 756,649 (382)
Blue‐Gray Papules on the Chest and Face
JEADV Clinical Practice, EarlyView.
Sanjana Likki +5 more
wiley +1 more source
Immunoprofiling Reveals GATA3 as a Prognostic Marker in Transformed Mycosis Fungoides
The Journal of Dermatology, EarlyView.ABSTRACT Transformed mycosis fungoides (TMF) is a rare, aggressive variant of cutaneous T‐cell lymphoma characterized by the presence of large neoplastic cells and poor clinical outcomes. A retrospective cohort of 22 TMF patients was analyzed using immunohistochemistry on formalin‐fixed, paraffin‐embedded (FFPE) tissue for GATA3 (n = 20), T‐bet (n = 22)
Bruno de Castro e Souza +5 more
wiley +1 more source
Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones
The Journal of Dermatology, EarlyView.ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda +2 more
wiley +1 more source
Specific cutaneous involvement indicating relapse of Burkitt's lymphoma [PDF]
, 1997 C Bachmeyer +7 more
openalex +1 more source
Personalized Cancer Vaccines in the Clinical Trial Pipeline
Asia-Pacific Journal of Clinical Oncology, EarlyView.This study analyzes the current landscape of personalized cancer vaccine clinical trials, highlighting trends in vaccine platforms, trial phases, and geographic distribution. Peptide and dendritic cell vaccines dominate early‐stage research, with promising immune responses observed in melanoma, glioblastoma, and urothelial cancer trials.
Liudmila Iamukova, Elena Alferova
wiley +1 more source
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions
Allergy, EarlyView.ABSTRACT Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. The clinical presentation of AD is heterogeneous and is characterized by a relapsing and remitting course. Most patients suffer from mild AD while approximately 5% to 20% experience severe disease activity, which often requires systemic treatment ...
Marjolein S. de Bruin‐Weller +9 more
wiley +1 more source
Hodgkin's Lymphoma with Cutaneous Involvement
Middle East Journal of Cancer, 2016 Cutaneous Hodgkin’s lymphoma is a rare disease (0.5% to 3.4%) which tends to be in the setting of an advanced disease and has a poor prognosis. Treatment of patients with cutaneous involvement of Hodgkin’s lymphoma is according to dissemination of ...
Ahmad Ameri, Ainaz Sourati
doaj
Elephantiasis nostras verrucosa: an atypical presentation following intrapelvic lymphoma [PDF]
, 2019 Elephantiasis nostras verrucosa is a progressively debilitating and disfiguring disease commonly presenting with verrucous, cobblestone-like papules, nodules, or plaques with nonpitting edema in the lower extremities.
Dahle, Sara E +3 more
core
Andrology, EarlyView.ABSTRACT Background Lichen sclerosus is a chronic, inflammatory, scarring disease of the skin that manifests mostly in the genital region. Objective We studied the histomorphological characteristics, grade, and pattern of inflammation in male pediatric patients with lichen sclerosus.
Valerie Flammang +10 more
wiley +1 more source
OX-40 signaling promotes tumorigenesis in CTCL by regulating ERK activation
Frontiers in ImmunologyIntroductionIn Cutaneous T-cell Lymphoma (CTCL), T cells can be activated either by cytokines produced by malignant T cells or through immunological synapses, such as the interaction between OX-40 and OX-40L on dendritic cells.
Evangelia Papadavid +9 more
doaj +1 more source